Literature DB >> 33569061

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

Daphne Mytilineos1,2,3, Chrysanthi Tsamadou1,2, Christine Neuchel1,2, Uwe Platzbecker4, Donald Bunjes5, Natalie Schub6, Eva Wagner-Drouet7, Gerald Wulf8, Nicolaus Kröger9, Niels Murawski10, Hermann Einsele11, Kerstin Schaefer-Eckart12, Sebastian Freitag13, Jochen Casper14, Martin Kaufmann15, Mareike Dürholt16, Bernd Hertenstein17, Stefan Klein18, Mark Ringhoffer19, Carlheinz R Mueller20,21, Sandra Frank21, Hubert Schrezenmeier1,2, Daniel Fuerst1,2, Joannis Mytilineos1,2,21.   

Abstract

T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.
Copyright © 2021 Mytilineos, Tsamadou, Neuchel, Platzbecker, Bunjes, Schub, Wagner-Drouet, Wulf, Kröger, Murawski, Einsele, Schaefer-Eckart, Freitag, Casper, Kaufmann, Dürholt, Hertenstein, Klein, Ringhoffer, Mueller, Frank, Schrezenmeier, Fuerst and Mytilineos.

Entities:  

Keywords:  HLA-DPB1; HLA-DPB1 expression; HLA-DPB1-permissiveness; graft-versus-host-disease; stem cell transplantation

Mesh:

Substances:

Year:  2021        PMID: 33569061      PMCID: PMC7868530          DOI: 10.3389/fimmu.2020.614976

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  33 in total

1.  Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities.

Authors:  Federico Sizzano; Laura Zito; Pietro Crivello; Roberto Crocchiolo; Luca Vago; Elisabetta Zino; Katharina Fleischhauer
Journal:  Blood       Date:  2010-09-16       Impact factor: 22.113

2.  Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.

Authors:  Ann M Moyer; Shahrukh K Hashmi; Cynthia M Kroning; Walter K Kremers; Steven R De Goey; Mrinal Patnaik; Mark Litzow; Dennis A Gastineau; William J Hogan; Eapen K Jacob; Justin D Kreuter; Laurie L Wakefield; Manish J Gandhi
Journal:  Eur J Haematol       Date:  2017-07-21       Impact factor: 2.997

3.  Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.

Authors:  Bianca Schöne; Sabine Bergmann; Kathrin Lang; Ines Wagner; Alexander H Schmidt; Effie W Petersdorf; Vinzenz Lange
Journal:  Hum Immunol       Date:  2017-11-07       Impact factor: 2.850

4.  The biological significance of HLA-DP gene variation in haematopoietic cell transplantation.

Authors:  E W Petersdorf; T Gooley; M Malkki; C Anasetti; P Martin; A Woolfrey; A Smith; E Mickelson; J A Hansen
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

5.  Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.

Authors:  Effie W Petersdorf; Mats Bengtsson; Dianne De Santis; Valerie Dubois; Katharina Fleischhauer; Ted Gooley; Mary Horowitz; J Alejandro Madrigal; Mari Malkki; Caroline McKallor; Yasuo Morishima; Machteld Oudshoorn; Stephen R Spellman; Jean Villard; Phil Stevenson; Mary Carrington
Journal:  J Clin Oncol       Date:  2020-06-01       Impact factor: 44.544

6.  HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.

Authors:  Bronwen E Shaw; Steven G E Marsh; Neema P Mayor; Nigel H Russell; J Alejandro Madrigal
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

7.  Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP.

Authors:  Pedro Cano; Marcelo Fernández-Viña
Journal:  Hum Immunol       Date:  2009-07-25       Impact factor: 2.850

8.  Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Authors:  Betül Oran; Rima M Saliba; Yudith Carmazzi; Marcos de Lima; Gabriela Rondon; Sairah Ahmed; Amin Alousi; Borje S Andersson; Paolo Anderlini; Michelle Alvarez; Qasier Bashir; Stefan Ciurea; Marcelo Fernandez-Vina; Chitra Hosing; Partow Kebriaei; Martin Korbling; Pedro Cano; Issa Khouri; David Marin; Yago Nieto; Amanda Olson; Uday Popat; Katy Rezvani; Muzaffar Qazilbash; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Blood       Date:  2018-01-31       Impact factor: 22.113

Review 9.  How to select the best available related or unrelated donor of hematopoietic stem cells?

Authors:  Jean-Marie Tiercy
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

10.  Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.

Authors:  Daniel Fuerst; Sandra Frank; Carlheinz Mueller; Dietrich W Beelen; Johannes Schetelig; Dietger Niederwieser; Jürgen Finke; Donald Bunjes; Nicolaus Kröger; Christine Neuchel; Chrysanthi Tsamadou; Hubert Schrezenmeier; Jan Beyersmann; Joannis Mytilineos
Journal:  Haematologica       Date:  2018-06-07       Impact factor: 9.941

View more
  2 in total

1.  Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Authors:  Anne-Marie Daull; Valérie Dubois; Hélène Labussière-Wallet; Fabienne Venet; Fiorenza Barraco; Sophie Ducastelle-Lepretre; Marie-Virginie Larcher; Marie Balsat; Lila Gilis; Gaëlle Fossard; Hervé Ghesquières; Maël Heiblig; Florence Ader; Vincent Alcazer
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

2.  Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bilateral pneumonia in Russians, living in the Chelyabinsk region (Russia).

Authors:  Tatiana A Suslova; Mikhail N Vavilov; Svetlana V Belyaeva; Alexander V Evdokimov; Daria S Stashkevich; Alexander Galkin; Ilya A Kofiadi
Journal:  Hum Immunol       Date:  2022-04-28       Impact factor: 2.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.